NEW YORK, May 30, 2022 /PRNewswire/ -- As per Zion Market Research study, The global Automated Breast Ultrasound Systems market was worth around USD 792.70 billion in 2021 and is estimated to grow to about USD 1911.43 billion by 2028, with a compound annual growth rate (CAGR) of approximately 15.80 percent over the forecast period. The report analyzes the digital remittance market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital remittance market.
Key Industry Insights & Finding of the Automated Breast Ultrasound Systems Market Reports:
- As per the analysis shared by our research analyst, the Automated Breast Ultrasound Systems Market is expected to grow annually at a CAGR of around 15.80 % (2022-2028).
- Through the primary research, it was established that the Automated Breast Ultrasound Systems Market was valued approximately USD 792.70 Billion in 2021 and is projected to reach to roughly USD 1911.43 Billion by 2028.
- The American Society of Cancer, about 281,550 new instances of breast cancer will be discovered in women in 2021, with 43,600 women dying from the disease.
- The ABUS market in the United States will be boosted by increased government programmes to raise awareness and educate women about breast cancer and the necessity of screening.
- The National Breast Cancer Foundation's awareness campaigns, and the Susan Komen Foundation's. These factors will boost demand for automated breast ultrasonography devices for breast cancer screening in dense breast tissue.
Zion Market Research published the latest report titled as "Automated Breast Ultrasound Systems Market By Product (Automated Breast Ultrasound System, Automated Breast Volume Scanner), By Application (Screening, Pre-operative Evaluation), End User (Hospitals, Diagnostic centers, Ambulatory Surgery Centers), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecasts 2022 – 2028." into their research database.
Automated Breast Ultrasound Systems Market: Overview
Breast cancer is one of the most frequent cancers in the world, and it is a severe health concern because it is the most common cancer in women. As a result, healthcare practitioners place a premium on early detection in order to lower morbidity and mortality rates and improve survival rates. Mammography and ultrasound are well-known tools for breast cancer screening and early detection. When used in conjunction with mammography, the breast ultrasound system has shown encouraging results in the diagnosis of tumours in women with thick breasts. Both mammography and conventional breast ultrasonography, on the other hand, had some technical limitations, paving the path for the development of ABUS.
The automated breast ultrasound (ABUS) system is a new technological advancement in the field of ultrasound imaging that was created to provide an operator-free system. ABUS is a repeatable system that produces high-resolution three-dimensional imaging. ABUS is known for its comfort, accuracy, and efficiency in handling. ABUS has been shown in several studies and research to have higher sensitivity, cancer detection rates, diagnostic accuracy rates, and picture quality. With the use of high-frequency transducers, recent improvements in ABUS systems have made it possible to reproduce superior quality images in a short amount of time.
The demand for automated breast ultrasound systems is being fueled by rising breast cancer prevalence and occurrences, a developing radiology market, and greater patient knowledge of the link between breast density and breast cancer. Furthermore, technological advancements in the development of improved imaging techniques, as well as increased government funding for breast cancer awareness, should boost market demand. Furthermore, heavy investments and extensive research, as well as the advantages of automated breast ultrasound systems such as 3D imaging, high quality imaging, coronal view, and rapid results with assurance of improved diagnostic results, are propelling the market for automated breast ultrasound systems forward. With an increase in the number of instances of breast cancer each year, particularly among women, and rising healthcare costs, the market for automated breast ultrasound systems (ABUS) is expected to rise rapidly in the future years.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/automated-breast-ultrasound-systems-market
Our Free Sample Report Includes:
- 2022 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 160 + Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of tables & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Zion Market Research methodology
Industry Dynamics:
Automated Breast Ultrasound Systems Market: Growth Drivers
- Demands for automated breast ultrasound systems to drive global market growth.
Breast cancer is the fifth biggest cause of mortality among women from cancer. Breast cancer affects as least one out of every four women diagnosed with cancer, and this worrying increase has prompted the need for efficient therapy. The ever-increasing prevalence of breast cancer around the world has sparked a spike in demand for automated breast ultrasonography equipment. The market for automated breast ultrasonography systems is growing due to an increase in the incidence of hereditary illnesses in women, as well as rising healthcare spending and favorable government regulations. According to the American Cancer Society, roughly 1.7 million new cancer cases are expected to be diagnosed by 2018, with over 600,000 Americans expected to die from cancer. The market for automated breast ultrasound systems has been boosted by increased R&D spending. Cancer Research UK has invested USD 518 million in cancer research across the country, with the goal of increasing cancer survival rates by 75% by 2034. By 2023, the group wants to spend up to 2.6 percent of GDP on cancer research. In addition, rising per capita income, favorable reimbursement policies, and increased knowledge of diagnostic system availability have supported the expansion of the automated breast ultrasound systems market.
Automated Breast Ultrasound Systems Market: Restraints
- Stringent regulations in various countries in Automated Breast Ultrasound Systems to hamper the market growth.
The use of imaging techniques has been restricted in a number of countries due to strict laws. Furthermore, the high cost of ultrasound systems compared to traditional cancer screening methods is expected to limit the growth of the global automated breast ultrasound system (ABUS) market. A new ABUS, for example, can cost around $300,000 on average. Although ultrasonography is quick and effective in detecting cancer, it is prone to false-positive biopsies, which is expected to slow market growth.
Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/automated-breast-ultrasound-systems-market
Automated Breast Ultrasound Systems Market: Opportunities
- Demands for automated breast ultrasound systems to bring growth opportunities for global market.
The number of patients is growing, and to diagnose any sort of cancer, an ultrasound or MRI is required to determine the cause or which body part is afflicted, which is positively impacting demand for breast ultrasound systems. Furthermore, the automated breast ultrasound systems market is influenced by the rise in healthcare expenditure, advancements in technology provided by different market players, advancements in healthcare infrastructure, and ore portable and less expensive diagnostic imaging tool, as compared to CT and MRI, breast associated disorder.
Global Automated Breast Ultrasound Systems Market: Segmentation
- The global Automated Breast Ultrasound Systems market is segregated based on product, application, end user and region.
By product, the market is classified into Automated Breast Ultrasound System amd Automated Breast Volume Scanner. By 2028, the automated breast ultrasound system segment is expected to grow at a faster rate. One of the primary factors boosting the worldwide automated breast ultrasound system is technological advances in breast cancer detection equipment. Several additional technologies are being developed by companies to improve cancer screening in people with thick breasts, enhancing the efficiency of breast cancer detection. ABUS innovations are also expected to solve flaws in traditional systems. Customer acceptance of improved cancer imaging will increase as a result of such technological advancements, boosting industry growth.
By end user, the Automated Breast Ultrasound Systems market is segmented into hospitals,diagonostic centers and ambulatory surgery centers. The diagnostic imaging centres segment will have a larger share in the forecasted period. The segmental growth will be accelerated by the expansion of diagnostic centre facilities for early identification and detection of malignant cells in the body. Breast cancer detection technologies will be adopted at a faster pace as specialist diagnosis tools and technology become more widely available. Furthermore, throughout the forecast period, improving infrastructure in diagnostic imaging centres in developing countries will support segmental growth.
Get More Insight before Buying@ : https://www.zionmarketresearch.com/inquiry/automated-breast-ultrasound-systems-market
List of Key Players of Automated Breast Ultrasound Systems Market:
- Canon Medical System
- GE Healthcare,Hitachi Ltd.
- koninklijke Philips N.V
- Metritrack Inc.
- Nova Medical Imaging Technology Co. Ltd
- Qview Medical Inc.
- SonoCine Inc.
- SuperSonic Imgine.
Key questions answered in this report:
- What are the growth rate forecast and market size for Automated Breast Ultrasound Systems Market?
- What are the key driving factors propelling the Automated Breast Ultrasound Systems Market forward?
- What are the most important companies in the Automated Breast Ultrasound Systems Market Industry?
- What segments does the Automated Breast Ultrasound Systems Market cover?
- How can I receive a free copy of the Automated Breast Ultrasound Systems Market sample report and company profiles?
Report Scope:
Free Brochure: https://www.zionmarketresearch.com/requestbrochure/automated-breast-ultrasound-systems-market
Recent Developments:
- November 2021-QView Medical, a leading breast cancer detection company based in the United States, has partnered with GE Healthcare, a well-known producer of cutting-edge medical technology. The former would be able to launch its QVCAD software on the latter's Invenia ABUS 2.0 platform as a result of this agreement (Automated Breast Ultrasound). Invenia ABUS 2.0 has an open platform technology that allows third-party AI technologies to be integrated. The product is a cancer-detecting supplementary breast screening technology that has been approved by the FDA.
- October 2019 - GE Healthcare and Premier Inc. worked to establish a concept for bringing same-day breast cancer diagnosis and treatment to the United States.
- December 2019 - At the 105th Annual Radiological Society of North America (RSNA) meeting, Ikonopedia showed improvements to its breast biopsy reporting tool aimed at increasing efficiency and clinical utility.
Regional Dominance:
- Increase the demand for better breast imaging technology and therapies.
According to the American Society of Cancer, about 281,550 new instances of breast cancer will be discovered in women in 2021, with 43,600 women dying from the disease. Breast cancer is becoming more common, which will increase the demand for better breast imaging technology and therapies. The ABUS market in the United States will be boosted by increased government programmes to raise awareness and educate women about breast cancer and the necessity of screening. The American Society of Cancer's National Breast Cancer Awareness (NBCA) month, the National Breast Cancer Foundation's awareness campaigns, and the Susan Komen Foundation's. These factors will boost demand for automated breast ultrasonography devices for breast cancer screening in dense breast tissue.
Global Automated Breast Ultrasound Systems Market is segmented as follows:
Automated Breast Ultrasound Systems Market: By Product Outlook (2022-2028)
- Automated Breast Ultrasound System
- Auromated Breast Volume Scanner
Automated Breast Ultrasound Systems Market: By Application Outlook (2022-2028)
- Screening
- Pre-operative Evaluation
Automated Breast Ultrasound Systems Market: By End User Outlook (2022-2028)
- Hospitals
- Diagonostic centers
- Ambulatory Surgery Centers
Automated Breast Ultrasound Systems Market: By Region Outlook (2022-2028)
North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Press Release For Automated Breast Ultrasound Systems Market: https://www.zionmarketresearch.com/news/global-automated-breast-ultrasound-systems-market
Browse Other Related Research Reports from Zion Market Research
- Women's Health Rehabilitation Products Market - Global Industry Analysis: The global Women's Health Rehabilitation Products Market accrued earnings worth approximately 3.30 (USD Billion) in 2021 and is predicted to gain revenue of about 9.14 (USD Billion) by 2028, is set to record a CAGR of nearly 5.1% over the period from 2022 to 2028.
- Digital Patient Monitoring Devices Market - Global Industry Analysis: The global Digital Patient Monitoring Devices Market accrued earnings worth approximately 63.1 (USD Billion) in 2020 and is predicted to gain revenue of about 447.3(USD Billion) by 2028, is set to record a CAGR of nearly 24.1% over the period from 2021 to 2028.
- Medical Equipment Calibration Services Market - Global Industry Analysis: The global Medical Equipment Calibration Services Market accrued earnings worth approximately 1.1 (USD Billion) in 2020 and is predicted to gain revenue of about 3.73 (USD Billion) by 2028, is set to record a CAGR of nearly 9.6% over the period from 2021 to 2028.
Browse through Zion Market Research's coverage of the Global Medical Device Industry
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: [email protected]
Website: https://www.zionmarketresearch.com/
Blog - https://zmrblog.com/
SOURCE Zion Market Research
![](https://rt.prnewswire.com/rt.gif?NewsItemId=IO72850&Transmission_Id=202205301030PR_NEWS_USPR_____IO72850&DateId=20220530)
Share this article